Relay Therapeutics, Inc. (RLAY)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$17.58−$0.1500 (−0.85%) on the dayAs of the close; data may be delayed.
RLAY price, last 12 months
Key stats
- Previous close
- $17.73
- Open
- $17.74
- Day range
- $17.42 – $18.01
- 52-week range
- $4.32 – $21.27
- Volume
- 2.1M
- Avg volume (20 days)
- 3.5M
- Market cap
- $3.8B
Performance
1W−6.7%
1M−9.7%
3M−5.3%
6M+73.7%
YTD+107.8%
1Y+288.9%
vs S&P 500, 1Y+272.2 pts
Technicals and fundamentals
About Relay Therapeutics, Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $3.8B